Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Scott Gettinger | Researchclopedia

Back to researchers

Scott Gettinger

Yale Cancer Center ORCID

634

Works

63,392

Citations

83

h-index

211

i10-index

Research Topics

Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers Lung Cancer Research Studies

Affiliations

University of North Carolina at Chapel Hill2009–2009

Christiana Care Health System2007–2007

Cedars-Sinai Medical Center2009–2010

Mount Sinai Beth Israel2004–2005

Memorial Hospital of South Bend2012–2012

Top Works

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

Suzanne L. Topalian,F. Stephen Hodi,et al.

201212,535 citations

Cancer Genomics and Diagnostics

Colorectal Cancer Treatments and Studies

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

H. Borghaei,L. Paz-Ares,et al.

20159,393 citations

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Roy S. Herbst,Jean‐Charles Soria,et al.

20145,219 citations

Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors

Lecia V. Sequist,Belinda A. Waltman,et al.

20113,534 citations

Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

David S. Ettinger,Douglas E. Wood,et al.

20221,386 citations

Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer

Scott Gettinger,Leora Horn,et al.

20151,189 citations

NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020

David S. Ettinger,Douglas E. Wood,et al.

20191,000 citations

NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021

David S. Ettinger,Douglas E. Wood,et al.

2021996 citations

Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial

Sarah B. Goldberg,Scott Gettinger,et al.

2016993 citations